Osteoporosis Flashcards
(64 cards)
Patient risk factors of OP
Advanced age
Ethnicity (Caucasian and Asian)
Family hx
Females > males
Low body weight
Medical Diseases RF OP
Diabetes
Eating disorder
GI disease
Hyperthyroidism
Hypogonadism
Menopause
RA and autoimmune
Lifestyle RF of OP
Smoking
Excessive alcohol intake
Low calcium intake
Low vitamin D
Physical inactivity
Medications that can ↑ risk or OP
PPIs
Lithum
GnRH
Depo-Provera
Aromatase inhibitors
Antiseizure meds
Chronic steroids
Thyroid hormone excess
SSRIs, TZD, tenofovir, loop
Differentiate osteoblasts from osteoclasts
Osteoblasts: Cells involved with bone formation
Osteoclasts: Cells involved with bone breakdown and resorption
Gold standard of diagnosing Osteo
Measure BMD through DEXA (DXA) scan
Measuring T-score and Z-score
Recommended age for BMD scan
Women: ≥65YO
Men: ≥70YO
What is the FRAX tool?
Estimates the risk of osteoporotic fractures in the next 10 yrs
How do you interpret a T-score?
Normal: ≥1
Osteopenia: -1 to -2.4
Osteoporosis: ≤2.5
Standard deviation of an average, healthy, young, white adult
Osteoporosis prevention (non-pharm)
- Medications that cause sedation or orthostasis (sedatives, hypnotics, narcotics)
- Weight-bearing exercises and muscle-strengthening
- Dietary calcium and Vitamin D
Recommended dose of calcium
1000-1200 mg elemental Ca
Don’t exceed 500-600 mg E Cal per dose because calcium absorption is saturable
Elemental Ca in products
Calcium carbonate: 40% (acidic-dependent) → take with food
Calcium citrate: 21% (not acid-dependent) → take with or without food
What is considered Vit D deficient
<30
Doing of Vit D
Cholecalciferol: 125-175 mg (5000-7000 IU) QD
Ergocalciferol: 1250 mcg (50000 IU) QW
ADR of calcium
Constipation
Criteria to initiate treatment for OP
T-score ≤2.5 in the spine, femoral neck, total hip or 1/3 radius OR
Presence of fragility fracture regardless of BMD
Criteria to initiate treatment for osteopenia if high risk
Low bone density (-1 to -2.5)
AND
FRAX score indicates a 10-yr probability of a major osteoporosis-related fracture ≥20% or a 10-yr hip fracture probability of ≥3%
Tx indicated for prevention
Bisphosphonates (except IV ibandronate)
Estrogen-based therapies (Raloxifene, Duavee)
Drugs indicated for tx of OP
Bisphosphonates
Denosumab
PTH analogs
Calcitonin
MOA of bisphophonates
Inhibiting osteoclast activity and bone resorption
PO bisphosphonates
Alendronate
Ibandronate
Risendronate
Albendronate
Fosamax, Binosto
Ibandronate
Boniva
Risedronate
Actonel, Atelvia